Dupixent Label Expands to Include Children Ages 1-11 with Eosinophilic Esophagitis
source: pixabay.com

Dupixent Label Expands to Include Children Ages 1-11 with Eosinophilic Esophagitis

In late January 2024, the U.S. Food and Drug Administration approved a label expansion for Dupixent (dupilumab). Dupixent, a monoclonal antibody targeting IL-4 and IL-13, is currently used to treat…

Continue Reading Dupixent Label Expands to Include Children Ages 1-11 with Eosinophilic Esophagitis
Dupixent Label Update Reflects Safety and Efficacy Results for Moderate-to-Severe Atopic Dermatitis with Severe Hand/Foot Involvement
source: shutterstock.com

Dupixent Label Update Reflects Safety and Efficacy Results for Moderate-to-Severe Atopic Dermatitis with Severe Hand/Foot Involvement

According to reporting from Healio Psoriatic Disease, the Food and Drug Administration (FDA) recently updated the label for Dupixent (dupilumab) in the indication of moderate-to-severe atopic dermatitis with moderate-to-severe hand…

Continue Reading Dupixent Label Update Reflects Safety and Efficacy Results for Moderate-to-Severe Atopic Dermatitis with Severe Hand/Foot Involvement
Research Suggests That Maternal and Infant Antibiotic Exposure Heightens EoE Risk
https://pixabay.com/en/mom-daughter-son-relationship-2208928/

Research Suggests That Maternal and Infant Antibiotic Exposure Heightens EoE Risk

Over the last three decades, researchers and doctors have noticed a concerning trend: increasing cases of eosinophilic esophagitis (EoE), a chronic digestive system disorder, in infants and children. In particular,…

Continue Reading Research Suggests That Maternal and Infant Antibiotic Exposure Heightens EoE Risk

Each Ankylosing Spondylitis Patient is Unique, This Study Reinforces that to Provide the Best Care, We Must Understand That

A New AS Study A recent study, published in Reumatologia aimed to evaluate how ankylosing spondylitis (AS) patients are coping with their condition on a psychological level. They wanted to investigate…

Continue Reading Each Ankylosing Spondylitis Patient is Unique, This Study Reinforces that to Provide the Best Care, We Must Understand That